AZD-5423
id:
azd-5423-180-10318522
title:
AZD-5423
text:
AZD-5423 is a nonsteroidal glucocorticoid and phase II experimental drug being developed by AstraZeneca and disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat respiratory diseases and in particular chronic obstructive pulmonary disease. It has completed a phase II clinical trial.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/AZD-5423
date created:
2013-04-14T03:33:29Z
date modified:
2024-09-05T13:54:00Z
main entity:
{"identifier":"Q15408423","url":"https://www.wikidata.org/entity/Q15408423"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/0/0d/AZD5423_structure.svg","width":620,"height":424}
fields total:
13
integrity:
16